2Wilcox J N, Okamoto E I, Nakahara K I, et al. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis., a role for circulating myofibroblast precursors[J]. Ann N Y Acad Sci, 2001,947 (10):68-90.
3Polberg K,Stepulak A,Stryjecka-Zimmer M,Kupisz K,Zawislak J.Squamous cell carcinoma antigen levels in patients with laryngeal cancer.Pol Merkuriusz Lek,2005,19(111):375 -376.
4Maeda Y,Segawa Y,Takigawa Net al.Clinical usefulness Of serum cytokeratin 19 fragment as a tumor marker for lung cancer.InternMed,1996,35(3):764 -778.
5GiovanellaL,PiantanidaR,CerianiL,et al.Immunoassay of neuron specific enolase (NSE) and serum fragments of cytokeratinl9 (CYFRA21-1)as tumor markers in small cell lung cancer:clinical evaluation and biological hypotheses.Int J Biol Markers,1997,12:22 -34.
6Molina R,Filella X,Auge JM,Bosch E,Torne A,Pahisa J,Lejarcegui JA,Rovirosa A,Mellado B,Ordi J,Biete A..CYFRA 21.1 in patients with cervical cancer:comparison with SCC and CEA.Anticancer Res,2005,25(3A):1765-1771.
7Puthucode-Easwaran S,Naik R,Athavale R,Handley G,Lopes A,Godfrey K,Hatem M.Comparison of pre-treatment CYFRA 21-1 and SCC-Antigen assay in primary cervical carcinoma-a preliminary report.J Obstet Gynaecol,2005,25(5):486 -488.
8Miedouge M, Devys A, Simon M, et al. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1,2,10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients [ J ]. Tumor Biol,2001,22 :19 -26.
9Nakata B, Chung YS, Kato Y, et al. Clinical significance of serum CYFRA21 - 1 in gastric cancer[ J]. Br J Cancer, 1996,73 ( 12 ) : 1529 - 1532.
10Zissimopoulos A, Stellos K, Permenopoulou V. The importance of the tumor marker CYFRA 21 - 1 in patients with lung cancer after surgery or chemotherapy[J]. Hell J Nucl Med, 2007,10(1) :62-64.
